The global thoracic surgery devices market size is expected to reach USD 1.08 billion by 2030, registering a CAGR of 6.42% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is driven by the growing aging population coupled with the increasing prevalence of thoracic diseases and conditions, such as lung cancer, chronic obstructive pulmonary disease (COPD), and cardiovascular diseases. Moreover, growing technological advancements are contributing to market growth. Furthermore, growing cases of lung cancer globally are supporting the market growth. Lung cancer is one of the most prevalent forms of cancer, which requires proper surgical intervention for many patients. Thoracic surgery plays an important role in the treatment of lung cancer, and the increasing prevalence of the disease is propelling the demand for thoracic surgery devices.
These devices encompass a wide range of equipment used in lung resections, biopsies, and other surgical procedures related to lung cancer diagnosis and treatment. As the global healthcare community continues to witness increasing cases of lung cancer, the market for thoracic surgery devices is projected to expand significantly. Increasing awareness about the importance of thoracic health is a significant growth driver of the overall market. Several public health initiatives, advocacy campaigns, and educational efforts have collectively contributed to an increased understanding among patients and healthcare professionals regarding the importance of timely diagnosis and treatment of thoracic diseases and conditions. This increased awareness has led to a surge in patient demand for thoracic surgeries, including lung resections, esophageal procedures, and cardiac surgeries, among others. As patients seek more medical attention for thoracic issues, healthcare providers are increasingly turning to thoracic surgery devices to meet the growing demand for these surgical procedures.
Request a free sample copy or view report summary: Thoracic Surgery Devices Market Report
By product, the forceps segment dominated the market with a share of over 26.12% in 2022 owing to its wide application scope in several thoracic procedures, the evolution of specialized designs for various applications, and the increasing adoption of minimally invasive surgical techniques
The lobectomy surgery type segment dominated the market in 2022 owing to the high prevalence of lung cancer, advancements in minimally invasive lobectomy, and continuous technological advancements
The hospital end-use segment held the highest share of the market in 2022 as hospitals are often hubs for a wide range of medical procedures, including surgeries, diagnostics, and treatments
In 2022, North America accounted for the highest share of about 38.87% owing to the region’s robust infrastructure, R&D capabilities, and a thriving technology sector
Grand View Research has segmented the global thoracic surgery devices market on the basis of product, surgery type, end-use, and region:
Thoracic Surgery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Clamps
Forceps
Graspers
Staplers
Scissors
Spreaders
Needle Holders
Others
Thoracic Surgery Devices Surgery Type Outlook (Revenue, USD Million, 2018 - 2030)
Lobectomy
Wedge Resection
Pneumonectomy
Others
Thoracic Surgery Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Others
Thoracic Surgery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Thoracic Surgery Devices Market
Medtronic plc
Cardio medical GmbH
Intuitive Surgical
Richard Wolf GmbH
Grena Ltd.
Dextera Surgical Inc.
Teleflex Inc.
Medela Healthcare
LivaNovaplc
Sklar Surgical Instruments
"The quality of research they have done for us has been excellent..."